 Akers Biosciences, Inc. the Company AKER, a developer of rapid health information technologies, today announced it will hold a conference call to discuss the licensing announcement with Premas Biotech for a Coronvirus vaccine candidate. Global biotech executive, co-founder and managing director at Premas, Dr. Prabuddha Kundu M.D., will discuss the process underway to seek fast track development of a vaccine candidate and related milestones that we hope to achieve and plan to announce as we progress. To access the replay, please dial 1-844-512-2921 in the U.S. and 1-412-317-6671 for international callers. 